[Radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : A multicentre phase III trial]
- PMID: 34379136
- PMCID: PMC8458171
- DOI: 10.1007/s00066-021-01826-w
[Radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : A multicentre phase III trial]
Comment on
-
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.Lancet Oncol. 2021 Feb;22(2):223-234. doi: 10.1016/S1470-2045(20)30601-X. Lancet Oncol. 2021. PMID: 33539742 Clinical Trial.
References
-
- André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, et al. Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 2017;35(16):1786–1794. doi: 10.1200/JCO.2016.68.6394. - DOI - PubMed
-
- Behringer K, Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, et al. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol. 2012;23(7):1093. doi: 10.1093/annonc/mdr575. - DOI - PubMed
-
- Borchmann P, Goergen H, Kobe C, Lohri A, et al. PET-guided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet. 2017;390(10114):2790–2802. doi: 10.1016/S0140-6736(17)32134-7. - DOI - PubMed
-
- Filippi AR, Meregalli S, Di Russo A, Levis M, Ciammella P, Buglione M, et al. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin’s lymphoma involving the mediastinum. Radiat Oncol. 2020 doi: 10.1186/s13014-020-01504-8. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical